Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-12

AUTHORS

You-Cheol Hwang, Ari Kim, Euna Jo, Yeoree Yang, Jae-Hyoung Cho, Byung-Wan Lee

ABSTRACT

BACKGROUND: Randomized clinical trials have shown the efficacy and safety of short-acting exenatide in patients with type 2 diabetes mellitus (T2DM). The aim of this observational study was to investigate the effectiveness and safety of exenatide twice a day in Korean patients with T2DM who are suboptimally controlled with oral hypoglycemic agents. METHODS: This study was a post hoc analysis of multi-center (71 centers), prospective, observational, single-arm, post-marketing study of short-acting exenatide 5 to 10 μg twice a day from March 2008 to March 2014 and analyzed those who finished the follow-up over 20 weeks of medication. Changes of hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), and body weight values before and after exenatide treatment were analyzed. Adverse events and adverse drug reactions were estimated in patients who were treated with exenatide at least once and for whom follow-up for safety has been completed. RESULTS: After 20 weeks treatment with exenatide, mean HbA1c and body weight were significantly reduced from 8.4% to 7.7% and from 83.4 kg to 80.2 kg, respectively (both p < 0.001). Subjects with higher baseline glucose and HbA1c levels showed an independent association with a greater reduction in glucose level. In addition, short duration of diabetes less than 5 years was an independent predictor for the improvement in glucose level. The majority of study subjects showed a reduction in both body weight and glucose level (63.3%) after exenatide treatment. In terms of safety profile, exenatide treatment was generally well-tolerated and the incidence of severe adverse event was rare (0.8%). The gastrointestinal side effects were most common and hypoglycemia was reported in 1.7% of subjects. CONCLUSION: In real clinical practice, 20 weeks treatment with short-acting exenatide was well tolerated and showed a significant body weight and glucose reduction in Korean patients with T2D who are suboptimally controlled with oral hypoglycemic agents. TRIAL REGISTRATION: ClinicalTirals.gov , number NCT02090673 , registered 14 February 2008. More... »

PAGES

68

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12902-017-0220-4

DOI

http://dx.doi.org/10.1186/s12902-017-0220-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1092345506

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29065865


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Asian Continental Ancestry Group", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Body Weight", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycated Hemoglobin A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoglycemic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peptides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Venoms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Kyung Hee University", 
          "id": "https://www.grid.ac/institutes/grid.289247.2", 
          "name": [
            "Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University School of Medicine, Kyung Hee University Hospital at Gangdong, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hwang", 
        "givenName": "You-Cheol", 
        "id": "sg:person.01016243504.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016243504.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AstraZeneca (South Korea)", 
          "id": "https://www.grid.ac/institutes/grid.467208.f", 
          "name": [
            "AstraZeneca, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Ari", 
        "id": "sg:person.013665771327.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013665771327.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AstraZeneca (South Korea)", 
          "id": "https://www.grid.ac/institutes/grid.467208.f", 
          "name": [
            "AstraZeneca, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jo", 
        "givenName": "Euna", 
        "id": "sg:person.01015333310.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01015333310.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Catholic University of Korea", 
          "id": "https://www.grid.ac/institutes/grid.411947.e", 
          "name": [
            "Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, 06591, Seoul, Seocho-gu, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "Yeoree", 
        "id": "sg:person.012471164711.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012471164711.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Catholic University of Korea", 
          "id": "https://www.grid.ac/institutes/grid.411947.e", 
          "name": [
            "Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, 06591, Seoul, Seocho-gu, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cho", 
        "givenName": "Jae-Hyoung", 
        "id": "sg:person.0772027363.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772027363.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yonsei University", 
          "id": "https://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Division of Endocrinology and Metabolism, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-Ro, 03722, Seoul, Seodaemun-Gu, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Byung-Wan", 
        "id": "sg:person.01260337416.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260337416.14"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/j.1464-5491.2010.02941.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000305496"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.2010.02941.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000305496"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.27.11.2628", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001990123"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/030079907x178766", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002109881"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clinthera.2008.08.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005757586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4093/dmj.2016.40.2.99", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007144437"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.28.5.1092", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007868854"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/dmso.s28387", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010919837"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc12-1235", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013104034"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1463-1326.2008.01018.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014171488"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1463-1326.2008.01018.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014171488"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dom.12293", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014466780"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12020-013-0090-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017863543", 
          "https://doi.org/10.1007/s12020-013-0090-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0111235", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022425647"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2009.726", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033039374"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4093/dmj.2011.35.4.303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034295930"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4093/dmj.2014.38.1.35", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038540596"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/03007995.2015.1103214", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039948974"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/03007995.2015.1103214", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039948974"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.diabet.2010.03.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045133498"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4093/dmj.2014.38.3.197", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045371507"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmp1103502", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046666249"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-014-3263-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052033454", 
          "https://doi.org/10.1007/s00125-014-3263-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00125-014-3263-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052033454", 
          "https://doi.org/10.1007/s00125-014-3263-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.28.5.1083", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053076188"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/dia.2011.0208", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059249597"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18433/j3g883", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068640780"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-146-7-200704030-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073709225"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077606859", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-12", 
    "datePublishedReg": "2017-12-01", 
    "description": "BACKGROUND: Randomized clinical trials have shown the efficacy and safety of short-acting exenatide in patients with type 2 diabetes mellitus (T2DM). The aim of this observational study was to investigate the effectiveness and safety of exenatide twice a day in Korean patients with T2DM who are suboptimally controlled with oral hypoglycemic agents.\nMETHODS: This study was a post hoc analysis of multi-center (71 centers), prospective, observational, single-arm, post-marketing study of short-acting exenatide 5 to 10\u00a0\u03bcg twice a day from March 2008 to March 2014 and analyzed those who finished the follow-up over 20\u00a0weeks of medication. Changes of hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), and body weight values before and after exenatide treatment were analyzed. Adverse events and adverse drug reactions were estimated in patients who were treated with exenatide at least once and for whom follow-up for safety has been completed.\nRESULTS: After 20\u00a0weeks treatment with exenatide, mean HbA1c and body weight were significantly reduced from 8.4% to 7.7% and from 83.4\u00a0kg to 80.2\u00a0kg, respectively (both p\u00a0<\u00a00.001). Subjects with higher baseline glucose and HbA1c levels showed an independent association with a greater reduction in glucose level. In addition, short duration of diabetes less than 5\u00a0years was an independent predictor for the improvement in glucose level. The majority of study subjects showed a reduction in both body weight and glucose level (63.3%) after exenatide treatment. In terms of safety profile, exenatide treatment was generally well-tolerated and the incidence of severe adverse event was rare (0.8%). The gastrointestinal side effects were most common and hypoglycemia was reported in 1.7% of subjects.\nCONCLUSION: In real clinical practice, 20\u00a0weeks treatment with short-acting exenatide was well tolerated and showed a significant body weight and glucose reduction in Korean patients with T2D who are suboptimally controlled with oral hypoglycemic agents.\nTRIAL REGISTRATION: ClinicalTirals.gov , number NCT02090673 , registered 14 February 2008.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12902-017-0220-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1028426", 
        "issn": [
          "1472-6823"
        ], 
        "name": "BMC Endocrine Disorders", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "name": "Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice", 
    "pagination": "68", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e1efe41b6374be3e2d902f422199474aa240b128c26ea796f05e939f0ed1606d"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29065865"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101088676"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12902-017-0220-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1092345506"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12902-017-0220-4", 
      "https://app.dimensions.ai/details/publication/pub.1092345506"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T20:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8684_00000570.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12902-017-0220-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12902-017-0220-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12902-017-0220-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12902-017-0220-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12902-017-0220-4'


 

This table displays all metadata directly associated to this object as RDF triples.

244 TRIPLES      21 PREDICATES      68 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12902-017-0220-4 schema:about N1c788f0a4d874681bf90b4d7b8284a03
2 N22d09aad412e4290adb137fa64dedc53
3 N23c005b4b25e49ada359f5b09a56e136
4 N502ef12f96594d428130e652d5e44336
5 N6a6a115b11ea4257aa122f55bb5e2ea4
6 N7b4d1e1f3a2a48c59320501fc655ac25
7 N837a2fc3ccbe4620bdd6c771187af912
8 Na2ffcc3f264841ed8d89fce3b4277a2e
9 Nb9af115cc8d4445c88ddf738e9458485
10 Nbcdff198b0d14916969df9b6b3f52ca8
11 Nc7eab361c364479ebb591594a378c82b
12 Neb27b7d60a2f45d8be4046a59e31af6e
13 Nf0bdb13908044969a7f7619aadca8291
14 Nf7ba88a0248c422db42b0571784e96ae
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author N3539e0f18c8848018c708571228deca4
18 schema:citation sg:pub.10.1007/s00125-014-3263-3
19 sg:pub.10.1007/s12020-013-0090-0
20 https://app.dimensions.ai/details/publication/pub.1077606859
21 https://doi.org/10.1001/jama.2009.726
22 https://doi.org/10.1016/j.clinthera.2008.08.006
23 https://doi.org/10.1016/j.diabet.2010.03.009
24 https://doi.org/10.1056/nejmp1103502
25 https://doi.org/10.1089/dia.2011.0208
26 https://doi.org/10.1111/dom.12293
27 https://doi.org/10.1111/j.1463-1326.2008.01018.x
28 https://doi.org/10.1111/j.1464-5491.2010.02941.x
29 https://doi.org/10.1185/030079907x178766
30 https://doi.org/10.1185/03007995.2015.1103214
31 https://doi.org/10.1371/journal.pone.0111235
32 https://doi.org/10.18433/j3g883
33 https://doi.org/10.2147/dmso.s28387
34 https://doi.org/10.2337/dc12-1235
35 https://doi.org/10.2337/diacare.27.11.2628
36 https://doi.org/10.2337/diacare.28.5.1083
37 https://doi.org/10.2337/diacare.28.5.1092
38 https://doi.org/10.4093/dmj.2011.35.4.303
39 https://doi.org/10.4093/dmj.2014.38.1.35
40 https://doi.org/10.4093/dmj.2014.38.3.197
41 https://doi.org/10.4093/dmj.2016.40.2.99
42 https://doi.org/10.7326/0003-4819-146-7-200704030-00003
43 schema:datePublished 2017-12
44 schema:datePublishedReg 2017-12-01
45 schema:description BACKGROUND: Randomized clinical trials have shown the efficacy and safety of short-acting exenatide in patients with type 2 diabetes mellitus (T2DM). The aim of this observational study was to investigate the effectiveness and safety of exenatide twice a day in Korean patients with T2DM who are suboptimally controlled with oral hypoglycemic agents. METHODS: This study was a post hoc analysis of multi-center (71 centers), prospective, observational, single-arm, post-marketing study of short-acting exenatide 5 to 10 μg twice a day from March 2008 to March 2014 and analyzed those who finished the follow-up over 20 weeks of medication. Changes of hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), and body weight values before and after exenatide treatment were analyzed. Adverse events and adverse drug reactions were estimated in patients who were treated with exenatide at least once and for whom follow-up for safety has been completed. RESULTS: After 20 weeks treatment with exenatide, mean HbA1c and body weight were significantly reduced from 8.4% to 7.7% and from 83.4 kg to 80.2 kg, respectively (both p < 0.001). Subjects with higher baseline glucose and HbA1c levels showed an independent association with a greater reduction in glucose level. In addition, short duration of diabetes less than 5 years was an independent predictor for the improvement in glucose level. The majority of study subjects showed a reduction in both body weight and glucose level (63.3%) after exenatide treatment. In terms of safety profile, exenatide treatment was generally well-tolerated and the incidence of severe adverse event was rare (0.8%). The gastrointestinal side effects were most common and hypoglycemia was reported in 1.7% of subjects. CONCLUSION: In real clinical practice, 20 weeks treatment with short-acting exenatide was well tolerated and showed a significant body weight and glucose reduction in Korean patients with T2D who are suboptimally controlled with oral hypoglycemic agents. TRIAL REGISTRATION: ClinicalTirals.gov , number NCT02090673 , registered 14 February 2008.
46 schema:genre research_article
47 schema:inLanguage en
48 schema:isAccessibleForFree true
49 schema:isPartOf N511a9d320ad2478788fa70071fa2b142
50 N7a10235fe90a40c4ab31ca1b240e3822
51 sg:journal.1028426
52 schema:name Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice
53 schema:pagination 68
54 schema:productId N370f3a2d78644c5da3c54806882c5af6
55 N473a7efb87684bd8986515a831e1fd60
56 N5eb3485669eb47948a7213c0ab5e1d56
57 N61e87b7c12e44b1f8f26454732574b61
58 Ne26915205ebe40cca2e0b53a0d2ca62a
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092345506
60 https://doi.org/10.1186/s12902-017-0220-4
61 schema:sdDatePublished 2019-04-10T20:55
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher Ne429173c6a3f4a0bba0a6d1180a1deb5
64 schema:url https://link.springer.com/10.1186%2Fs12902-017-0220-4
65 sgo:license sg:explorer/license/
66 sgo:sdDataset articles
67 rdf:type schema:ScholarlyArticle
68 N1c788f0a4d874681bf90b4d7b8284a03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Venoms
70 rdf:type schema:DefinedTerm
71 N22d09aad412e4290adb137fa64dedc53 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Body Weight
73 rdf:type schema:DefinedTerm
74 N23c005b4b25e49ada359f5b09a56e136 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Humans
76 rdf:type schema:DefinedTerm
77 N3539e0f18c8848018c708571228deca4 rdf:first sg:person.01016243504.53
78 rdf:rest N75ef41606cf94d6d9c77e10726fe0ee2
79 N370f3a2d78644c5da3c54806882c5af6 schema:name nlm_unique_id
80 schema:value 101088676
81 rdf:type schema:PropertyValue
82 N473a7efb87684bd8986515a831e1fd60 schema:name readcube_id
83 schema:value e1efe41b6374be3e2d902f422199474aa240b128c26ea796f05e939f0ed1606d
84 rdf:type schema:PropertyValue
85 N502ef12f96594d428130e652d5e44336 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Prospective Studies
87 rdf:type schema:DefinedTerm
88 N511a9d320ad2478788fa70071fa2b142 schema:issueNumber 1
89 rdf:type schema:PublicationIssue
90 N5eb3485669eb47948a7213c0ab5e1d56 schema:name pubmed_id
91 schema:value 29065865
92 rdf:type schema:PropertyValue
93 N61e87b7c12e44b1f8f26454732574b61 schema:name dimensions_id
94 schema:value pub.1092345506
95 rdf:type schema:PropertyValue
96 N6a6a115b11ea4257aa122f55bb5e2ea4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Peptides
98 rdf:type schema:DefinedTerm
99 N75ef41606cf94d6d9c77e10726fe0ee2 rdf:first sg:person.013665771327.20
100 rdf:rest N995d3011c4da4434b3735d88ca798fc9
101 N7a10235fe90a40c4ab31ca1b240e3822 schema:volumeNumber 17
102 rdf:type schema:PublicationVolume
103 N7b4d1e1f3a2a48c59320501fc655ac25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Adult
105 rdf:type schema:DefinedTerm
106 N837a2fc3ccbe4620bdd6c771187af912 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Glycated Hemoglobin A
108 rdf:type schema:DefinedTerm
109 N896d090460b141699686983bd7399233 rdf:first sg:person.0772027363.30
110 rdf:rest Na18aac7ae82e474188537975b2d269d8
111 N995d3011c4da4434b3735d88ca798fc9 rdf:first sg:person.01015333310.41
112 rdf:rest Na76b5358cd824fa5bfa1c538968d8ed3
113 Na18aac7ae82e474188537975b2d269d8 rdf:first sg:person.01260337416.14
114 rdf:rest rdf:nil
115 Na2ffcc3f264841ed8d89fce3b4277a2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Male
117 rdf:type schema:DefinedTerm
118 Na76b5358cd824fa5bfa1c538968d8ed3 rdf:first sg:person.012471164711.68
119 rdf:rest N896d090460b141699686983bd7399233
120 Nb9af115cc8d4445c88ddf738e9458485 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Diabetes Mellitus, Type 2
122 rdf:type schema:DefinedTerm
123 Nbcdff198b0d14916969df9b6b3f52ca8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Middle Aged
125 rdf:type schema:DefinedTerm
126 Nc7eab361c364479ebb591594a378c82b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Female
128 rdf:type schema:DefinedTerm
129 Ne26915205ebe40cca2e0b53a0d2ca62a schema:name doi
130 schema:value 10.1186/s12902-017-0220-4
131 rdf:type schema:PropertyValue
132 Ne429173c6a3f4a0bba0a6d1180a1deb5 schema:name Springer Nature - SN SciGraph project
133 rdf:type schema:Organization
134 Neb27b7d60a2f45d8be4046a59e31af6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Hypoglycemic Agents
136 rdf:type schema:DefinedTerm
137 Nf0bdb13908044969a7f7619aadca8291 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Asian Continental Ancestry Group
139 rdf:type schema:DefinedTerm
140 Nf7ba88a0248c422db42b0571784e96ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Blood Glucose
142 rdf:type schema:DefinedTerm
143 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
144 schema:name Medical and Health Sciences
145 rdf:type schema:DefinedTerm
146 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
147 schema:name Clinical Sciences
148 rdf:type schema:DefinedTerm
149 sg:journal.1028426 schema:issn 1472-6823
150 schema:name BMC Endocrine Disorders
151 rdf:type schema:Periodical
152 sg:person.01015333310.41 schema:affiliation https://www.grid.ac/institutes/grid.467208.f
153 schema:familyName Jo
154 schema:givenName Euna
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01015333310.41
156 rdf:type schema:Person
157 sg:person.01016243504.53 schema:affiliation https://www.grid.ac/institutes/grid.289247.2
158 schema:familyName Hwang
159 schema:givenName You-Cheol
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016243504.53
161 rdf:type schema:Person
162 sg:person.012471164711.68 schema:affiliation https://www.grid.ac/institutes/grid.411947.e
163 schema:familyName Yang
164 schema:givenName Yeoree
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012471164711.68
166 rdf:type schema:Person
167 sg:person.01260337416.14 schema:affiliation https://www.grid.ac/institutes/grid.15444.30
168 schema:familyName Lee
169 schema:givenName Byung-Wan
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260337416.14
171 rdf:type schema:Person
172 sg:person.013665771327.20 schema:affiliation https://www.grid.ac/institutes/grid.467208.f
173 schema:familyName Kim
174 schema:givenName Ari
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013665771327.20
176 rdf:type schema:Person
177 sg:person.0772027363.30 schema:affiliation https://www.grid.ac/institutes/grid.411947.e
178 schema:familyName Cho
179 schema:givenName Jae-Hyoung
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772027363.30
181 rdf:type schema:Person
182 sg:pub.10.1007/s00125-014-3263-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052033454
183 https://doi.org/10.1007/s00125-014-3263-3
184 rdf:type schema:CreativeWork
185 sg:pub.10.1007/s12020-013-0090-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017863543
186 https://doi.org/10.1007/s12020-013-0090-0
187 rdf:type schema:CreativeWork
188 https://app.dimensions.ai/details/publication/pub.1077606859 schema:CreativeWork
189 https://doi.org/10.1001/jama.2009.726 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033039374
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1016/j.clinthera.2008.08.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005757586
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1016/j.diabet.2010.03.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045133498
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1056/nejmp1103502 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046666249
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1089/dia.2011.0208 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059249597
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1111/dom.12293 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014466780
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1111/j.1463-1326.2008.01018.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1014171488
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1111/j.1464-5491.2010.02941.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1000305496
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1185/030079907x178766 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002109881
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1185/03007995.2015.1103214 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039948974
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1371/journal.pone.0111235 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022425647
210 rdf:type schema:CreativeWork
211 https://doi.org/10.18433/j3g883 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068640780
212 rdf:type schema:CreativeWork
213 https://doi.org/10.2147/dmso.s28387 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010919837
214 rdf:type schema:CreativeWork
215 https://doi.org/10.2337/dc12-1235 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013104034
216 rdf:type schema:CreativeWork
217 https://doi.org/10.2337/diacare.27.11.2628 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001990123
218 rdf:type schema:CreativeWork
219 https://doi.org/10.2337/diacare.28.5.1083 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053076188
220 rdf:type schema:CreativeWork
221 https://doi.org/10.2337/diacare.28.5.1092 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007868854
222 rdf:type schema:CreativeWork
223 https://doi.org/10.4093/dmj.2011.35.4.303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034295930
224 rdf:type schema:CreativeWork
225 https://doi.org/10.4093/dmj.2014.38.1.35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038540596
226 rdf:type schema:CreativeWork
227 https://doi.org/10.4093/dmj.2014.38.3.197 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045371507
228 rdf:type schema:CreativeWork
229 https://doi.org/10.4093/dmj.2016.40.2.99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007144437
230 rdf:type schema:CreativeWork
231 https://doi.org/10.7326/0003-4819-146-7-200704030-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073709225
232 rdf:type schema:CreativeWork
233 https://www.grid.ac/institutes/grid.15444.30 schema:alternateName Yonsei University
234 schema:name Division of Endocrinology and Metabolism, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-Ro, 03722, Seoul, Seodaemun-Gu, South Korea
235 rdf:type schema:Organization
236 https://www.grid.ac/institutes/grid.289247.2 schema:alternateName Kyung Hee University
237 schema:name Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University School of Medicine, Kyung Hee University Hospital at Gangdong, Seoul, South Korea
238 rdf:type schema:Organization
239 https://www.grid.ac/institutes/grid.411947.e schema:alternateName Catholic University of Korea
240 schema:name Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, 06591, Seoul, Seocho-gu, South Korea
241 rdf:type schema:Organization
242 https://www.grid.ac/institutes/grid.467208.f schema:alternateName AstraZeneca (South Korea)
243 schema:name AstraZeneca, Seoul, South Korea
244 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...